TrialThe New England journal of medicine2018
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
Michael R Migden et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
711 papers cite itlatest 60 shown
this paperpooled ittrialcites it